Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy

Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy

Josefina Marin, María Laura Acosta Felquer, Enrique R Soriano Rheumatology Unit, Internal Medical Serivces, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina Abstract: Certolizumab pegol (CZP) is a pegylated huma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marin J, Acosta Felquer ML, Soriano ER
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
certolizumab pegol
tumor necrosis factor-α inhibitors
ankylosing spondilitys
non-radiographic axial spondyloarthritis
efficacy
safety
Diseases of the musculoskeletal system
RC925-935
Acceso en línea:https://doaj.org/article/d7db2130f257427ab00260fb3fb0170b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/d7db2130f257427ab00260fb3fb0170b

Ejemplares similares